Journals / Glokom Katarakt / 2014 / Cilt: 9 - Sayı: 2

Our Results of Ex-Press Mini Glaucoma Implant Treatment in Patients with Secondary Glaucoma Refractory to Filtration Surgery

Filtrasyon Cerrahisine Dirençli Sekonder Glokom Olgularında Ex-Press Mini Glokom İmplant Tedavisi Sonuçlarımız

Pages
93–96
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, ex-press implant surgery was evaluated as an effective and reliable method, with a shorter learning curve

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: We aimed to evaluate the success and complications of ex-press mini glaucoma implant treatment which is applied in patients with secondary glaucoma refractory to filtration surgery.
📊
Key Findings & Data:Materials and Methods: Ten eyes of the 10 patients who had glaucomatous etiology and did not benefit from trabeculectomy treatment were included in the study.
💡
Conclusion & Impact:As a result, ex-press implant surgery was evaluated as an effective and reliable method, with a shorter learning curve
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: We aimed to evaluate the success and complications of ex-press mini glaucoma implant treatment which is applied in patients with secondary glaucoma refractory to filtration surgery. Materials and Methods: Ten eyes of the 10 patients who had glaucomatous etiology and did not benefit from trabeculectomy treatment were included in the study. In the etiology, glaucoma was detected following keratoplasty in 4 eyes, as neovascular glaucoma in 4 eyes, due to the anterior chamber lens in 1 eye, and after repair of corneal perforation in 1 eye . All patients were treated with ex-press mini glaucoma implant. Topical antibiotic and corticosteroid therapy were given to all patients following implantation. Results: Regulation of intraocular pressure was achieved in 7 patients (70%). The mean intraocular pressure were statistically significantly less in the controls compared to preoperative period (p <0.05). In the early postoperative period, 2 eyes displayed hypertonia (20%), 1 eye hypotonia (10%), 1 eye tube endothelial contact (10%), while in the late period, tube occlusion was detected in 3 eyes (30%), tube dislocation in 1 eye (10%), and implant erosion in 2 eyes (20%), respectively. As a result, ex-press implant surgery was evaluated as an effective and reliable method, with a shorter learning curve

Özet

Amaç: Filtrasyon cerrahisine dirençli sekonder glokom olgularında uygulanan ex-press mini glokom implant tedavisinin başarı ve komplikasyonlarını değerlendimeyi amaçladık. Gereç ve Yöntem: Trabekülektomi tedavisinden fayda görmeyen sekonder glokomatöz etyolojili 10 hastanın 10 gözü çalışmaya dahil edildi. Glokom etyolojisinde 4 gözde keratoplasti sonrası glokom, 4 gözde neovasküler glokom, 1 gözde ön kamara lensine bağlı glokom, 1 gözde korneal perforasyon tamiri sonrası glokom saptandı. Tüm hastalara ex-press mini glokom implant tedavisi yapıldı. İmplantasyon sonrası tüm hastalara topikal antibiyotik ve kortikosteroid tedavisi verildi. Bulgular: Yedi hastada göz içi basınç (GİB) regülasyonu sağlandı (%70). Ortalama GİB preoperatif döneme göre kontrollerde istatistiksel olarak daha az bulundu (p<0.05). Postoperatif erken dönemde 2 gözde hipertoni(%20), 1 gözde hipotoni (%10), 1 gözde tüp endotel teması(%10), geç dönemde ise 3 gözde tüp tıkanması (%30), 1 gözde tüp dislokasyonu (%10), 2 gözde implant erozyonu (%20) saptandı. Sonuç olarak ex-press implant cerrahisi öğrenme eğrisi kısa olan, dirençli glokom olgularında etkin ve güvenli bir yöntem olarak değerlendirildi

🔖

Cite This Article

ŞEN, E., ÜN, E. Ş., YÜKSEL, B., ÜNSAL, S. K., UYAR, M. (2014). Our Results of Ex-Press Mini Glaucoma Implant Treatment in Patients with Secondary Glaucoma Refractory to Filtration Surgery. Glokom Katarakt, Cilt: 9 - Sayı: 2, 93–96. https://ajindex.com/articles/210378

References (13)

  1. Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ 2004;82:887-8. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 3rd Edition 2008.
  2. Bagnis A, Papadia M, Scotto R, et al. Current and emerging medical therapies in the treatment of glaucoma. Expert Opin Emerg Drugs 2011;16293-307.
  3. Carreras FJ, Rica R, Delgado AV. Modeling the patterns of visual field loss in glaucoma. Optom Vis Sci 2011;88:63-79.
  4. Gavric M, Gabric N, Dekaris I, et al. Selective laser trabecu- loplasty in the treatment of pseudoexfoliation glaucoma in patients allergic to all anti-glaucoma drops. Coll Antropol 2010;34:275-7.
  5. Francis BA, Singh K, Lin SC, et al. Novel glaucoma proce- dures: a report by the American Academy of Ophthalmology Ophthalmology. 2011;118:1466-80. Sarkisian SR. The ex-press mini glaucoma shunt: technique and experience. Middle East Afr J Ophthalmol 2009;16:134-7.
  6. Novak-Laus K, Milicic J, Tedeschi-Reiner E, et al. Analysis of the qualitative dermatoglyphics of the digito-palmar complex in patients with primary open angle glaucoma. Coll Antropol 2006;30:163-70.
  7. Caprioli J, Coleman AL. İntraocular pressure fluctuation a risk factor for visual field progression at low intraocular pres- sures in the advanced glaucoma intervention study. Ophthal- mology 2008;115:1123-9 De Jong LA. The Ex-PRESS glaucoma shunt versus trabecu- lectomy in open-angle glaucoma: a prospective randomized study. Adv Ther 2009;26:336-45. Bull H, von Wolff K, Körber N, et al. Three-year canalo- plasty outcomes for the treatment of open-angle glaucoma: European study results. Graefes Arch Clin Exp Ophthalmol 2011;249:1537-45.
  8. Papaconstantinou D, Georgalas I, Karmiris E, et al. Trabecu- lectomy with OloGen versus trabeculectomy for the treatment of glaucoma: a pilot study. Acta Ophthalmol 2010;88:80-5.
  9. Dahan E, Carmichael TR. Implantation of a miniature glau- coma device under a scleral flap. J Glaucoma 2005;14:98-102.
  10. De Feo F, Bagnis A, Bricola G, et al. Efficacy and safety of a steel drainage device implanted under a scleral flap. Can J Ophthalmol 2009;44:457-62.
  11. Maris PJ Jr, Ishida K, Netland PA. Comparison of trabeculec- tomy with Ex-PRESS miniature glaucoma device implanted under scleral flap. J Glaucoma 2007;16:14-9.
  12. Elgin U, Batman A, İlhan B, ve ark. terminal glokom olgularında, ex-press implantın göz içi basıncını düşürmedeki etkisi. MN Ophthalmol 2005;4:292-4.
  13. Ates H, Palamar M, Yagci A, et al. Evaluation of Ex-PRESS mini glaucoma shunt